Drug Patents owned by J And J Consumer Inc

1. List of Pepcid Ac drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6814978

(Pediatric)

J AND J CONSUMER INC Process for preparing a soft tablet
Feb, 2022

(1 year, 3 months ago)

Do you want to check out PEPCID AC patents from before 2022?

Drugs and Companies using FAMOTIDINE ingredient

Market Authorisation Date: 24 September, 1998

Treatment: NA

Dosage: TABLET, CHEWABLE;ORAL

How can I launch a generic of PEPCID AC before it's patent expiration?
More Information on Dosage

2. List of Pepcid Complete drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6814978

(Pediatric)

J AND J CONSUMER INC Process for preparing a soft tablet
Feb, 2022

(1 year, 3 months ago)

Do you want to check out PEPCID COMPLETE patents from before 2022?

Drugs and Companies using CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE ingredient

Market Authorisation Date: 16 October, 2000

Treatment: NA

Dosage: TABLET, CHEWABLE;ORAL

How can I launch a generic of PEPCID COMPLETE before it's patent expiration?
More Information on Dosage

3. List of Zyrtec-d 12 Hour drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7226614 J AND J CONSUMER INC Tablet comprising cetirizine and pseudoephedrine
Jun, 2022

(11 months ago)

US7014867 J AND J CONSUMER INC Tablet comprising cetirizine and pseudoephedrine
Jun, 2022

(11 months ago)

Do you want to check out ZYRTEC-D 12 HOUR patents from before 2022?

Drugs and Companies using CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE ingredient

Market Authorisation Date: 09 November, 2007

Treatment: Treatment of seasonal and perennial allergic rhinitis symptoms

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of ZYRTEC-D 12 HOUR before it's patent expiration?
More Information on Dosage

ZYRTEC-D 12 HOUR family patents

3

United States

3

European Union

2

Japan

2

Korea, Republic of

1

Spain

1

Austria

1

Hong Kong

1

Malaysia

1

Denmark

1

Czech Republic

1

Poland

1

Germany

1

Russia

1

China

1

Brazil

1

Canada

1

Estonia

1

Argentina

1

Norway

1

New Zealand

1

Croatia

1

Romania

1

Cyprus

1

Portugal

1

Taiwan

1

Mexico

1

Australia

1

Costa Rica

1

Bulgaria

1

South Africa

1

Slovakia

1

Colombia

1

Slovenia

1

Hungary

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in